Human stem cell-engineered iNKT cells (blue) attack a human blood cancer cell (magenta).

The findings identify a potential strategy to make bone marrow transplants safer without disrupting their ability to fight cancer. While the protective effects iNKT cells have against graft-versus-host disease has been observed in patients in the clinic, this discovery has not yielded an available therapy because iNKT cells are so rare. The new study outlines a new method for producing large numbers of iNKT cells from donated cord blood. The researchers estimate one cord blood donation could produce more than 10,000 doses of iNKT cells for clinical use.

Read the full article: Cell Therapy Could Improve Bone Marrow Transplant Safety therapy